First, I want to clarify something. When the legislation was being discussed, there was no consensus on the fact that there should be a list. On the contrary, all the NGOs were opposed to the creation of that limited list. As Mrs. Perkins explained, we said that there was no need to include such a list in the Canadian legislation since none was required by the WTO decision.
As far as we are concerned, it is not difficult to identify what is a pharmaceutical product. The only requirement should be to obtain a compulsory license to manufacture the product. It is not difficult to determine what is a pharmaceutical product and it is not necessary to have a limited list.
Thank you.